Amylyx to stop development of rare brain disorder drug after trial failure-February 2024-www.financetom.com

Amylyx to stop development of rare brain disorder drug after trial failure

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Amylyx to stop development of rare brain disorder drug after trial failure

Aug 27, 2025 4:35 AM

Aug 27 (Reuters) - Amylyx Pharmaceuticals ( AMLX ) said

on Wednesday it will discontinue development of its experimental

drug for a rare brain disorder after the treatment failed to

show benefit in a mid-stage trial.

(Reporting by Kamal Choudhury in Bengaluru)

Previous page： US buys 4.65 million barrels for emergency oil stockpile Next page： Airbus plans Space Systems restructuring as consolidation talks continue

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

US buys 4.65 million barrels for emergency oil stockpile

Jul 29, 2024

July 29 (Reuters) - The U.S. Department of Energy said on Monday it had finalized a contract to purchase 4.65 million barrels of crude oil for the Strategic Petroleum Reserve, for delivery to the Bayou Choctaw site in Louisiana during the last three months of the year. Exxon Mobil ( XOM ) will supply 3.9 million barrels of the contract,...

Airbus plans Space Systems restructuring as consolidation talks continue

Jul 29, 2024

PARIS, July 29 (Reuters) - Airbus is drawing up a new turnaround plan for its Space Systems business, industry sources said, adding talks over potential European consolidation to fend off competition include Italy's Leonardo as well as France's Thales. Airbus has launched an immediate cash containment plan across the wider Defence and Space division, aims to announce the specific Space...

--Canadian Pacific Kansas City Keeps Quarterly Dividend at CA$0.19 ($0.14) a Share, Payable Oct. 28 to Shareholders on Sept. 27

Jul 29, 2024

12:20 PM EDT, 07/29/2024 (MT Newswires) -- Price: 82.67, Change: +0.40, Percent Change: +0.49 ...

Cinemark Likely to Beat Q2 Expectations Even As Year-Ago Comparisons Seem Tough, Wedbush Says

Jul 29, 2024

12:24 PM EDT, 07/29/2024 (MT Newswires) -- Cinemark (CNK) is poised to beat Wall Street expectations when it reports its Q2 financial results later this week, Wedbush analysts said Monday in a new research note Monday. The cinema chain is likely going to outpace consensus views on revenue and earnings before interest, taxes, depreciation and amortization for the three months...